The Founding Team at Priothera is responsible for steering the company's strategic direction, securing funding, and establishing key business and scientific partnerships. They also oversee product development and commercialization efforts, ensuring alignment with the company's mission to develop orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.
View all